Skip to main content
Premium Trial:

Request an Annual Quote

City of Hope To Use Sequenom's MassArray Platform

NEW YORK (GenomeWeb News) - The City of Hope National Medical Center has purchased Sequenom's MassArray genetic analysis system and portfolio of application tools, Sequenom said today.
 
City of Hope will use MassArray for its molecular marker research and individualized cancer care initiatives, the company said.
 
Garry Larson, an associate research scientist at City of Hope, said in a statement that the center will use Sequenom's platform for quantitative gene expression and methylation studies.
 
Larson added that the center will use the genotyping system "as an integral part of our ongoing research both to identify individuals at high risk for developing cancer, and to aid in the development of therapeutic modalities based on the unique genetic profile of a given patient."
 
Financial details of the purchase were not disclosed.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.